Palmeiras published its 2025 financial statements and independent auditors' report on Wednesday, outlining investments across the season. It said it invested about R$ 847 million in player signings.
Richemont (CFRHF) looks undervalued after investor overreaction, with resilient growth, low RSI and cheap multiples. Click here to read my analysis.
Though sustainable investing inflows are down sharply from their highs, trillions remain invested in sustainable assets. Renewable energy has been a bright spot as demand surges for data centers and ...
Since September 2025, Columbia Banking System has been in a holding pattern, posting a small loss of 1.3% while floating around $26.21. Is there a buying opportunity in Columbia Banking System, or ...
Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced its financial results for the fourth quarter ended December 31, 2025. Key Highlights Since Strive's Public Listing in ...
DTE Energy’s DTK is rated a sell, as the issue does not adequately compensate for downside exposure. Click to learn more about DTE’s baby bonds, DTK and DTG.
DocGo Inc. (NASDAQ:DCGO) Q4 2025 Earnings Call Transcript March 16, 2026 DocGo Inc. misses on earnings expectations. Reported EPS is $-1861353.15452 EPS, expectations were $-0.142. Operator: Good ...
STAFFORD, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast" or the "Company"), a global leader in advanced battery technologies, announced today its ...
This is HealthEquity, Inc.'s fourth quarter fiscal 2026 earnings conference call. Before I turn the call over to Scott for our prepared remarks, we note that the press release announcing our fourth ...
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced its financial results for the fourth quarter and full-year 2025, along ...
Some of the changes made to global tax initiatives under the Trump administration had been coming for years. Others, not so ...
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive ...